Edition:
India

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

33.65USD
10:33pm IST
Change (% chg)

$1.60 (+4.99%)
Prev Close
$32.05
Open
$32.40
Day's High
$33.65
Day's Low
$32.40
Volume
32,280
Avg. Vol
85,220
52-wk High
$37.20
52-wk Low
$18.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.98 December 18 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 1 1 1
(2) OUTPERFORM 7 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.78 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 7 0.08 0.10 0.00 0.10
Quarter Ending Mar-18 3 0.09 0.10 0.08 0.10
Year Ending Dec-17 9 0.23 0.40 0.00 0.28
Year Ending Dec-18 9 0.21 0.60 0.00 0.35
Earnings (per share)
Quarter Ending Dec-17 7 -0.98 -0.89 -1.02 -1.02
Quarter Ending Mar-18 3 -0.80 -0.71 -0.97 -0.78
Year Ending Dec-17 8 -3.73 -3.25 -3.96 -3.30
Year Ending Dec-18 8 -3.44 -2.93 -4.24 -2.89

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.05 0.08 0.03 50.00
Quarter Ending Jun-17 0.05 0.08 0.03 50.00
Quarter Ending Mar-17 0.06 0.08 0.01 20.00
Quarter Ending Dec-16 0.07 0.08 0.01 13.64
Quarter Ending Sep-16 0.06 0.08 0.01 17.55
Earnings (per share)
Quarter Ending Sep-17 -0.93 -1.01 0.08 -8.14
Quarter Ending Jun-17 -0.94 -0.90 0.04 -4.66
Quarter Ending Mar-17 -0.85 -0.94 0.09 -10.59
Quarter Ending Dec-16 -0.84 -0.95 0.11 -13.64
Quarter Ending Sep-16 -0.89 -0.64 0.25 -28.29

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.08 0.08 0.07 0.05 0.10
Quarter Ending Mar-18 0.09 0.09 0.10 0.10 0.10
Year Ending Dec-17 0.23 0.23 0.25 0.22 0.28
Year Ending Dec-18 0.21 0.21 0.22 0.22 0.35
Earnings (per share)
Quarter Ending Dec-17 -0.98 -0.98 -0.97 -0.94 -1.02
Quarter Ending Mar-18 -0.80 -0.80 -0.71 -0.71 -0.78
Year Ending Dec-17 -3.73 -3.73 -3.75 -3.61 -3.30
Year Ending Dec-18 -3.44 -3.49 -3.55 -3.41 -2.89

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 1 0 1 1
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 1 0 1 1
Year Ending Dec-18 1 0 2 1